Bayer enters into collaboration with Seattle Genetics for development of anticancer drugs

06:07 AM | June 26, 2013 | Deepti Ramesh

Bayer says that its Bayer HealthCare subgroup has entered into a new antibody-drug conjugate (ADC) collaboration with biotechnology company Seattle Genetics (Bothell, WA). Bayer, under the deal, will...